To learn more, please call our Research Department at (513) 936-5388 or (888) 649-4800. Or email abradley@ohcmail.com
- CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
- CONSOLIDATION/MAINTENANCE THERAPY FOLLOWING SECOND LINE THERAPY
- Study number:
- CLL 11 SCRI
- Protocol title:
- Phase II Trial of Ofatumumab for Older Patients and Patients who Refuse Fludarabine-based Regimens with Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status:
- Open